European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Respiratory drug tenders in Portugal

Respiratory drug tenders in Portugal: 1,060 listed on GranTender since 2024. The median awarded contract value is about €410,000 (35 contracts with a stated value). Buyers with the most tenders: Unidade Local de Saúde de Santa Maria, E. P. E. (109), Unidade Local de Saúde do Alto Alentejo, E. P. E. (48) and Unidade Local de Saúde de Gaia/Espinho, E. P. E. (47); suppliers with the most contract awards: Glaxosmithkline-Prod. Farmacêuticos, Lda. (109), Labesfal-Lab. Almiro, Sa. (98) and Astrazeneca-Produtos Farmacêuticos,lda. (74). Sources: Portal BASE and TED. In 2025 the median contract value was €2,200; 36% of contracts drew a single bid (8.8 bids on average). Data as of 18 November 2026; updated daily.

Tenders
1,060
Open tenders
0
Awards
1,054
Awarded value awarded
€38,369,903
Awarded value contract
€50,528,871
Median contract value contract
≈ €2,900
Median contract value awarded
≈ €410,000
Average bids per contract
10.0
Tenders in 2025
366 +37% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

No records yet.

Latest tenders

TenderBuyerEstimated valueStatusPublished
Fornecimento de Medicamentos do aparelho respiratório na área da saúde, celebrado pelos serviços partilhados do ministério da saúde n.º 2024/899.Hospital do Divino Espírito Santo de Ponta Delgada, EPER—Awarded22 July 2026
Medicamentos do aparelho respiratório - AQ 2024-899)Unidade Local de Saúde do Oeste, EPE—Awarded16 July 2026
060102002026 - 2026/0295 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 304/2023 - Medicamentos do grupo 4: sangue, 490/2023 - Medicamentos usados em afeções cutâneas, 495/2023 - Medicamentos do aparelho geniturinário, 899/2024 - Aparelho Respiratório, 671/2023 – Medicamentos Diversos, 961/2024 - Medicamentos diversos, 1439/2025 - Corretivos da volémia e 1589/2025 - Medicamentos diversosUnidade Local de Saúde de Coimbra, E. P. E.—Awarded2 July 2026
060102002026 - 2026/0295 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 304/2023 - Medicamentos do grupo 4: sangue, 490/2023 - Medicamentos usados em afeções cutâneas, 495/2023 - Medicamentos do aparelho geniturinário, 899/2024 - Aparelho Respiratório, 671/2023 – Medicamentos Diversos, 961/2024 - Medicamentos diversos, 1439/2025 - Corretivos da volémia e 1589/2025 - Medicamentos diversosUnidade Local de Saúde de Coimbra, E. P. E.—Awarded2 July 2026
060102002026 - 2026/0295 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 304/2023 - Medicamentos do grupo 4: sangue, 490/2023 - Medicamentos usados em afeções cutâneas, 495/2023 - Medicamentos do aparelho geniturinário, 899/2024 - Aparelho Respiratório, 671/2023 – Medicamentos Diversos, 961/2024 - Medicamentos diversos, 1439/2025 - Corretivos da volémia e 1589/2025 - Medicamentos diversosUnidade Local de Saúde de Coimbra, E. P. E.—Awarded2 July 2026
060102002026 - 2026/0295 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 304/2023 - Medicamentos do grupo 4: sangue, 490/2023 - Medicamentos usados em afeções cutâneas, 495/2023 - Medicamentos do aparelho geniturinário, 899/2024 - Aparelho Respiratório, 671/2023 – Medicamentos Diversos, 961/2024 - Medicamentos diversos, 1439/2025 - Corretivos da volémia e 1589/2025 - Medicamentos diversosUnidade Local de Saúde de Coimbra, E. P. E.—Awarded2 July 2026
060102002026 - 2026/0295 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 304/2023 - Medicamentos do grupo 4: sangue, 490/2023 - Medicamentos usados em afeções cutâneas, 495/2023 - Medicamentos do aparelho geniturinário, 899/2024 - Aparelho Respiratório, 671/2023 – Medicamentos Diversos, 961/2024 - Medicamentos diversos, 1439/2025 - Corretivos da volémia e 1589/2025 - Medicamentos diversosUnidade Local de Saúde de Coimbra, E. P. E.—Awarded2 July 2026
261G000645 - IVACAFTOR 150 MG COMPUnidade Local de Saúde de Santa Maria, E. P. E.€285,481Awarded9 June 2026
261G000414 - AQUISIÇÃO DE IVACAFTOR 75 MG + TEZACAFTOR 50 MG + ELEXACAFTOR 100 MG COMP PARA O ANO DE 2026Unidade Local de Saúde de Santa Maria, E. P. E.—Awarded20 May 2026
261G000645 - AQUISIÇÃO DE IVACAFTOR 150 MG COMP PARA O ANO DE 2026Unidade Local de Saúde de Santa Maria, E. P. E.—Awarded12 May 2026
261G000643 - AQUISIÇÃO DE IVACAFTOR 75 MG COMP PARA O ANO DE 2026Unidade Local de Saúde de Santa Maria, E. P. E.—Awarded12 May 2026
261Y000305 - UISIÇÃO DE MEDICAMENTOS DIVERSOS - 899/2024Unidade Local de Saúde de Santa Maria, E. P. E.—Awarded28 April 2026
261Y000305 - UISIÇÃO DE MEDICAMENTOS DIVERSOS - 899/2024Unidade Local de Saúde de Santa Maria, E. P. E.—Awarded28 April 2026
C.Central Medicamentos 2026 - 2026/242 LUMACAFTOR+IVACAFTOR ( I )Unidade Local de Saúde de Santa Maria, E. P. E.€6,573,843Awarded27 April 2026
C.Central Medicamentos 2026 - 2026/242 LUMACAFTOR+IVACAFTOR ( III )Unidade Local de Saúde de Santa Maria, E. P. E.€98,415Awarded27 April 2026
C.Central Medicamentos 2026 - 2026/242 LUMACAFTOR+IVACAFTOR ( II)Unidade Local de Saúde de Santa Maria, E. P. E.€1,092,704Awarded27 April 2026
261G000446 - OMALIZUMAB CANETAS (várias dosagens)Unidade Local de Saúde de Santa Maria, E. P. E.€1,359,774Awarded21 April 2026
261G000248 - C.Central Medicamentos 2026 - 2026/0130 Lote 2Unidade Local de Saúde de Santa Maria, E. P. E.€610,339Awarded30 January 2026
261G000248 - C.Central Medicamentos 2026 - 2026/0130 Lote 1Unidade Local de Saúde de Santa Maria, E. P. E.€1,325,692Awarded30 January 2026
261G000248 - C.Central Medicamentos 2026 - 2026/0130 Lote 3Unidade Local de Saúde de Santa Maria, E. P. E.€29,525Awarded30 January 2026

Competition and prices

In 2025, half of the contracts were worth between €390 and €14,000, with a median of €2,200 (320 contracts with a stated contract value). Contracts drew 8.8 bids on average (median 10) and 36% drew a single bid — based on 80 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 22% and the share of single-bid contracts rose from 12% to 36%. The usual procedures: restricted procedure (80%), open procedure (20%) — of 44 tenders with a stated procedure.

The most contracts went to Glaxosmithkline-Prod. Farmacêuticos, Lda. (109), Labesfal-Lab. Almiro, Sa. (98) and Astrazeneca-Produtos Farmacêuticos,lda. (74) — together 27% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024262€1,800 (contract value)€340 – €13,00010.812% (124)
2025348€2,200 (contract value)€390 – €14,0008.836% (80)
2026 (so far)427€4,100 (contract value)€970 – €24,0009.523% (64)
All years1,054€2,900 (contract value)€520 – €18,00010.021% (285)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

In the last 12 months, 0 companies won their first contract in our records here — 0% of the 431 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33670000 Medicinal products for the respiratory system

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Market reports

Respiratory drugs and antihistamines by city

Respiratory drugs and antihistamines in other countries

Respiratory drugs and antihistamines across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Where can I find respiratory drug tenders in Portugal?
GranTender lists them in one place, from Portal BASE and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most respiratory drug tenders in Portugal?
By number of contracts won: Glaxosmithkline-Prod. Farmacêuticos, Lda. (109), Labesfal-Lab. Almiro, Sa. (98), Astrazeneca-Produtos Farmacêuticos,lda. (74).
Which buyers publish the most respiratory drug tenders in Portugal?
By number of tenders: Unidade Local de Saúde de Santa Maria, E. P. E. (109), Unidade Local de Saúde do Alto Alentejo, E. P. E. (48), Unidade Local de Saúde de Gaia/Espinho, E. P. E. (47).
Which CPV codes belong to “Respiratory drugs and antihistamines”?
33670000 Medicinal products for the respiratory system; plus tenders without a usable CPV code whose title names the topic.
How many bids do respiratory drug tenders in Portugal receive on average?
In 2025, contracts drew 8.8 bids on average (median 10) and 36% drew a single bid — based on 80 contracts with a known number of bids.
How much are contracts for respiratory drug tenders in Portugal worth?
In 2025, half of the contracts were worth between €390 and €14,000, with a median of €2,200 (320 contracts with a stated contract value). Compared with 2024, in 2025 the median value rose 22% and the share of single-bid contracts rose from 12% to 36%.
Which procedures are used for respiratory drug tenders in Portugal?
The usual procedures: restricted procedure (80%), open procedure (20%) — of 44 tenders with a stated procedure.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.